Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,664,100
New position
Shares Held
35,000
first reported quarter
Ownership
0.040%
of shares outstanding
% of Portfolio
2.70%
of 13F equity value
Holder Rank
#112
of 299 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Knoll Capital Management, LLC holds $72,284,754 across 10 Biotechnology names. ABVX ranks #7 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MGTX |
MeiraGTx Holdings plc
|
1,250,000 | $16,887,500 | |
| 2 | ALDX |
Aldeyra Therapeutics, Inc.
|
5,475,516 | $11,662,849 | |
| 3 | OCUL |
Ocular Therapeutix, Inc
|
1,150,400 | $11,296,928 | |
| 4 | ENTX |
Entera Bio Ltd.
|
5,881,879 | $10,410,925 | |
| 5 | NUVB |
Nuvation Bio Inc.
|
1,598,591 | $9,079,996 | |
| 6 | ELTX |
Elicio Therapeutics, Inc.
|
1,211,957 | $4,738,751 | |
| 7 | ABVX |
Abivax S.A.
This page
|
35,000 | $4,664,100 | |
| 8 | ABEO |
Abeona Therapeutics Inc.
|
485,515 | $3,000,482 |
All Filings in ABVX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,664,100 | 35,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||